Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment

about

Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment

Item

http://www.wikidata.org/entity/Q36384717

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Immunogenicity and acceptance ...... pegylated-interferon treatment

@ast

Immunogenicity and acceptance ...... pegylated-interferon treatment

@en

type

Item

label

Immunogenicity and acceptance ...... pegylated-interferon treatment

@ast

Immunogenicity and acceptance ...... pegylated-interferon treatment

@en

prefLabel

Immunogenicity and acceptance ...... pegylated-interferon treatment

@ast

Immunogenicity and acceptance ...... pegylated-interferon treatment

@en

P1476

Immunogenicity and acceptance ...... pegylated-interferon treatment

@en

P2093

Alejandro Jimenez

http://www.w3.org/2001/XMLSchema#string

Alvaro Torres

http://www.w3.org/2001/XMLSchema#string

Antonio Z Gimeno-García

http://www.w3.org/2001/XMLSchema#string

Carlos Casanova

http://www.w3.org/2001/XMLSchema#string

Manuel Hernández-Guerra

http://www.w3.org/2001/XMLSchema#string

Marta Carrillo

http://www.w3.org/2001/XMLSchema#string

Miriam Hernández-Porto

http://www.w3.org/2001/XMLSchema#string

Patricia de Molina

http://www.w3.org/2001/XMLSchema#string

Yanira González-Méndez

http://www.w3.org/2001/XMLSchema#string

P2860

Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective

Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys.

Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009.

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

A novel influenza A (H1N1) vaccine in various age groups.

P304

e48610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0048610

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tomàs Pumarola Suñe

Enrique Quintero

P577

2012-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233397036

http://www.w3.org/2001/XMLSchema#string

P698

23144908

http://www.w3.org/2001/XMLSchema#string

P932

3493585

http://www.w3.org/2001/XMLSchema#string